–Alright, let’s get the “news which I cannot comment about” out of the way (since a few of you have asked already this week): https://investor.lilly.com/news-releases/news-release-details/lillys-bamlanivimab-ly-cov555-administered-etesevimab-ly-cov016 Pronounced “eh-tez-ev-ah-mab”. Thank you for your understanding. –On the whole, good news this week. Global new cases continue to drop. In the US, new case numbers continue to drop. Hospitalization …

Continue reading “Coronavirus Update: 11 Feb 2021”

–Cases across the US continue to go down. I’m sure you saw the headline this week when the number of vaccinations in one day exceeded the number of new cases for the first time. With 1.3 million vaccinations last week, even before the Federal vaccination supercenters got rolling, the Biden administration is already well on …

Continue reading “Coronavirus Update 04 Feb 2021”

—Overall, global daily cases are going down, but again with high local variance. Some parts of Europe are still experiencing higher case numbers. Spain and France, for example. South America is broadly trending down again—including Brazil (that will be important to note in a minute). Same for South Africa. —Leading off, we have yet another …

Continue reading “Coronavirus Update: 28 Jan 2021”

–We start this week with more news that I cannot comment on: https://investor.lilly.com/news-releases/news-release-details/lillys-neutralizing-antibody-bamlanivimab-ly-cov555-prevented Thank you for your understanding. –We’ve got some pictures to start, because the story they tell is beautiful: At the top, that is the rate of new cases of COVID nationwide. You are in the green pretty much from sea to shining …

Continue reading “Coronavirus Update: 21 Jan 2021”

–Alright, let’s do this… –Stateside, similarly to Thanksgiving, the New Year’s Eve pop in new cases has dropped in most states. Nationally, the hospital admissions and census continue to drop. They are still considerably higher than the Great Memorial Day Experiment/Riots peak in the summer, and in fact are only now back to the March-May …

Continue reading “Coronavirus Update 14 Jan 2021”

–Greetings fellow citizens! I am happy to provide you with a report of the progress since receiving my experimental vaccination 8 days ago. As you have learned from many of the leading internet experts on the mechanism of action of the vaccine, and its predictable effects, integration with my DNA is now complete. Mutagenesis for …

Continue reading “Coronavirus Update 07 Jan 2021”

Ebola– Only news of significance is that the FDA approved Ebanga (ansuvimab-zykl), a monoclonal antibody to Ebola which was derived from antibodies isolated from a patient who had survived an Ebola outbreak in the 1990s. Ebanga first saw use in the 2018 outbreak (the other side of the DRC from the most recent). So very …

Continue reading “Ebola and Coronavirus Update 23 Dec 2020”

Ebola: Coronavirus: –Vaccines. Moderna seems likely to be approved. Both Moderna and Pfizer’s vaccines work the same way. Vaccination has started, and is favoring frontline health care workers in ERs, urgent cares, and ICUs, followed by hospital staff in general, and rolling out from there. I have NOT received a vaccine yet–the state department of …

Continue reading “Ebola and Coronavirus Update: 17 Dec 2020”

Ebola –No new cases reported this week. What is new, and slipping under the radar, is the review of the response to the previous outbreak in the DRC (2018 through early this year) surfaced. The short version is here where you will find that the report was not provided to WHO partners and leaders in …

Continue reading “Ebola and Coronavirus Update: 10 Dec 2020”

Ebola Update: –No new cases. Coronavirus Update: –A bit to talk about this week. First, top-line numbers. This part of the week is the critical point for any Thanksgiving bump here in the States. Since most patients will have symptoms 2-5 days after exposure, plus 48-72 hour turnaround time allowance for testing, and we should …

Continue reading “Ebola and Coronavirus Update: 03 Dec 2020”